Efficacy News and Research

RSS

Cancer cells use tactics to avoid being recognised by immunotherapy agents

Researchers have found that bowel cancer cells have a mechanism by which they can switch off some key molecules on their surfaces and thus escape being recognised and killed by the immunotherapy agents.

15 Apr 2019

Stem cells from patient's own bone marrow holds great potential for osteoarthritis

Stem cells collected from the patient's own bone marrow holds great interest as a potential therapy for osteoarthritis of the knee because of their ability to regenerate the damaged cartilage.

15 Apr 2019

Novo Biosciences achieves major milestones in its new drug to treat heart disease and DMD

Novo Biosciences Inc., has achieved several major milestones in its mission of bringing its breakthrough drug candidate, trodusquemine, to market as a potential regenerative medicine treatment for heart disease and Duchenne muscular dystrophy.

15 Apr 2019

FDA approves new treatment for adults with metastatic bladder cancer

The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.

12 Apr 2019

One-third of people with cancer use complementary and alternative medicines

A stunning one-third of people with a cancer diagnosis use complementary and alternative medicines such as meditation, yoga, acupuncture, herbal medicine, and supplements.

12 Apr 2019

Experimental drug may be twice as good at fighting vision loss as previously thought

In studies with lab-grown human cells and in mice, Johns Hopkins Medicine researchers have found that an experimental drug may be twice as good at fighting vision loss as previously thought.

11 Apr 2019

New strategy for editing and repairing genetic mutation associated with microduplications

Scientists at UMass Medical School have developed a strategy for editing and repairing a particular type of genetic mutation associated with microduplications using CRISPR/Cas9 and a seldom-used DNA repair pathway.

11 Apr 2019

FDA warns against using uncleared medical devices to assess or diagnose concussion

Today, the U.S. Food and Drug Administration is warning the public not to use medical devices marketed to consumers that claim to help assess, diagnose or manage head injury, including concussion, traumatic brain injury (TBI) or mild TBI.

11 Apr 2019

New electronic sensors detect parameters essential to ensure human comfort and safety

From astronauts and submariners to miners and rescue workers, people who operate in small enclosed spaces need good air quality to work safely and effectively.

11 Apr 2019

Researchers develop potent and safe vaccine against deadly MERS

A collaborative team from The University of Texas Medical Branch at Galveston, Saudi Arabia and Canada developed a potent and safe vaccine that protects against the deadly Middle East respiratory syndrome, or MERS. The findings recently were published in The Journal of Infectious Diseases.

10 Apr 2019

Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression

Parkinson's disease affects between 7 and 10 million people worldwide and the number of people diagnosed is soaring due to the ageing population.

10 Apr 2019

$FDA approves new osteoporosis drug for postmenopausal women with high fracture risk$

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).

9 Apr 2019

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.

9 Apr 2019

Cancer vaccine injected into tumour could kill all cancer cells

Researchers have developed an experimental cancer vaccine that when injected into a single tumour can help trigger the immune system to kill the cancer cells circulating within the body. The results of the study titled, “Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination,” were published in the latest issue of the journal Nature Medicine, this week, Monday.

9 Apr 2019

New study could help optimize SSRI dosing and minimize adverse effects in teens

In a simulated study, exposure to and maximum blood concentrations of two selective serotonin reuptake inhibitors - commonly used to treat anxiety and depression in adolescents - differed depending on whether the teens modeled were poor, normal, rapid, or ultra-rapid metabolizers of the SSRIs.

9 Apr 2019

Efficacy News and Research

Cancer cells use tactics to avoid being recognised by immunotherapy agents

Stem cells from patient's own bone marrow holds great potential for osteoarthritis

Novo Biosciences achieves major milestones in its new drug to treat heart disease and DMD

FDA approves new treatment for adults with metastatic bladder cancer

One-third of people with cancer use complementary and alternative medicines

Experimental drug may be twice as good at fighting vision loss as previously thought

New strategy for editing and repairing genetic mutation associated with microduplications

FDA warns against using uncleared medical devices to assess or diagnose concussion

New electronic sensors detect parameters essential to ensure human comfort and safety

Researchers develop potent and safe vaccine against deadly MERS

Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

Cancer vaccine injected into tumour could kill all cancer cells

New study could help optimize SSRI dosing and minimize adverse effects in teens

Scientists visualize immune cells fighting blood cancer for the first time

New clinical trials to investigate combination immunotherapy for treating advanced cancers

Online cannabis oils contain dangerous amounts of psychoactive THC

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

Scientists use a promiscuous inhibitor to uncover cancer drug targets

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News